Artwork

内容由questdrugtesting提供。所有播客内容(包括剧集、图形和播客描述)均由 questdrugtesting 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

The epidemic within the pandemic

24:36
 
分享
 

已归档的系列专辑 ("不活跃的收取点" status)

When? This feed was archived on January 03, 2024 08:08 (3M ago). Last successful fetch was on October 16, 2023 10:25 (6M ago)

Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间,但仍然无法截取有效的播客收取点

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 282121263 series 2854810
内容由questdrugtesting提供。所有播客内容(包括剧集、图形和播客描述)均由 questdrugtesting 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Today’s podcast will share results of a recent Quest Diagnostics Health Trends™ publication, The Opioid Epidemic Within the COVID-19 Pandemic: Drug Monitoring in 2020, which was published in the October 2020 edition of Population Health Management. The study objective was to better understand the relationship between the COVID-19 pandemic and the drug epidemic in the US. To achieve this objective, investigators analyzed urine specimen results from an analytic cohort of 872,762 specimens from all 50 states and the District of Columbia. Findings demonstrated significant changes in prescription drug monitoring and positivity rates for many drugs of concern. Important study results and conclusions discussed will include:

  • Clinical drug testing decreased significantly during the pandemic period
  • Nonprescribed positivity for fentanyl, heroin, and other drugs of concern increased significantly
  • Many dangerous drug combinations, including combinations with fentanyl, increased significantly
  • The impact of the COVID-19 pandemic on the treatment of patients at risk for substance use disorder
  • The role of clinical drug monitoring

This episode features Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology, and Justin Niles, lead medical informatics analyst for Quest Diagnostics Health Trends™.

----more----

You may download a PDF version of this presentation here >>

  continue reading

23集单集

Artwork
icon分享
 

已归档的系列专辑 ("不活跃的收取点" status)

When? This feed was archived on January 03, 2024 08:08 (3M ago). Last successful fetch was on October 16, 2023 10:25 (6M ago)

Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间,但仍然无法截取有效的播客收取点

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 282121263 series 2854810
内容由questdrugtesting提供。所有播客内容(包括剧集、图形和播客描述)均由 questdrugtesting 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Today’s podcast will share results of a recent Quest Diagnostics Health Trends™ publication, The Opioid Epidemic Within the COVID-19 Pandemic: Drug Monitoring in 2020, which was published in the October 2020 edition of Population Health Management. The study objective was to better understand the relationship between the COVID-19 pandemic and the drug epidemic in the US. To achieve this objective, investigators analyzed urine specimen results from an analytic cohort of 872,762 specimens from all 50 states and the District of Columbia. Findings demonstrated significant changes in prescription drug monitoring and positivity rates for many drugs of concern. Important study results and conclusions discussed will include:

  • Clinical drug testing decreased significantly during the pandemic period
  • Nonprescribed positivity for fentanyl, heroin, and other drugs of concern increased significantly
  • Many dangerous drug combinations, including combinations with fentanyl, increased significantly
  • The impact of the COVID-19 pandemic on the treatment of patients at risk for substance use disorder
  • The role of clinical drug monitoring

This episode features Dr Jeff Gudin, senior medical advisor, Quest Diagnostics Drug Monitoring and Toxicology, and Justin Niles, lead medical informatics analyst for Quest Diagnostics Health Trends™.

----more----

You may download a PDF version of this presentation here >>

  continue reading

23集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南